Comprehensive genetic dissection of poxvirus membrane assembly and function
Comprehensive genetic dissection of poxvirus membrane assembly and function
批准号:
10575027
负责人:
Kartik Chandran
金额:
$25.2万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-12-01 至 2024-11-30
关键词:
ActinsAmino AcidsBehavior assessmentBindingBiochemicalBiological AssayBiologyC-Type LectinsC-terminalCell surfaceCellsCollaborationsComplementComplexCowpox virusCytoplasmCytoplasmic TailDataDefectDevelopmentDissectionGPA33 geneGene CombinationsGenerationsGeneticGenetic ScreeningGenetic studyGrowthHumanImmunityIndividualInfectionInternetIntracellular MembranesLibrariesMammalsMass Spectrum AnalysisMediatingMembrane ProteinsMolecularMonkeypox virusMorphogenesisMutagenesisMutateMutationNatureOncolyticOrthopoxvirusPersonsPhenotypePoint MutationPopulationPoxviridaeProteinsProteomicsPublic HealthReportingRiskRoleSensitivity and SpecificitySerial PassageSeriesSiteSmallpoxSurfaceTherapeuticTherapeutic antibodiesVaccinatedVaccinationVaccinesVaccinia virusViralViral ProteinsVirionVirulenceVirusWorkZoonosescancer therapycell motilityextracellularfitnessgenomic locusimprovedin vivoloss of functionmembermembrane assemblymembrane biogenesismutantmutation screeningnew epidemicnext generation sequencingnoveloncolytic vectorparticlepoxvirus vectorspreventprotein protein interactionprototypereverse geneticstissue tropismtransmission processvirus geneticsvirus host interactionvirus virus interaction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The zoonotic potential of members of the genus Orthopoxvirus (orthopoxviruses) of mammal- infecting poxviruses represent a continued threat to global public health. A hallmark of the complex biology of orthopoxvirus multiplication in the host cell cytoplasm is the generation of two distinct infectious forms—intracellular mature virions (IMV), which remain largely cell- associated, and enveloped virions (EV), which are critical for extracellular viral spread. EVs bear a unique complement of eight virus-encoded membrane proteins at their surface that influence tissue tropism, long-range in vivo dissemination, and ultimately, virulence; provide key targets for vaccine-induced and therapeutic antibodies; and are important determinants of the therapeutic potential of oncolytic poxvirus vectors. Despite their importance, a comprehensive understanding of EVs is challenged by the complex networks of virus-host and virus-virus interactions that underlie their morphogenesis and function. Our overall objective is to unravel these functional protein interaction networks through a combination of genetic and proteomic approaches. Using a new platform for unbiased and deep mutagenesis of any genomic locus in the prototypic orthopoxvirus, vaccinia virus (VACV), we conducted deep-mutational scans (DMS) of two EV proteins, A33 and A34, in the context of infectious viral particles and identified novel regiospecific mutations that enhance EV fitness. We will elucidate the mechanisms of action of these mutants. In parallel, we will perform genetic modifier and proteomic screens to uncover new functional interactions of A33/A34 with viral and host proteins. Collectively, these studies will provide new information on how EVs—critical for both the virulence of orthopoxviruses and their utility as oncolytic vectors—assemble, egress, and spread to new cells during infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Einstein BSL3 Laboratory Renovation to Advance Biomedical Research on RNA Viruses of Pandemic Potential
-
批准号:10611691
-
项目类别:
-
资助金额:$710.07万
-
财政年份:2022
-
负责人:Kartik Chandran
-
依托单位:
Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.
-
批准号:10320993
-
项目类别:
-
资助金额:$230.41万
-
财政年份:2021
-
负责人:Kartik Chandran
-
依托单位:
Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.
-
批准号:10264634
-
项目类别:
-
资助金额:$244.83万
-
财政年份:2021
-
负责人:Kartik Chandran
-
依托单位:
Structure-based Vaccine Design for CCHFV
-
批准号:10405068
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2020
-
负责人:Kartik Chandran
-
依托单位:
Structure-based Vaccine Design for CCHFV
-
批准号:10624297
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2020
-
负责人:Kartik Chandran
-
依托单位:
Structure-based Vaccine Design for CCHFV
-
批准号:10202440
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2020
-
负责人:Kartik Chandran
-
依托单位:
Project II: Biologics Engineering and Antibody Mechanism of Action
-
批准号:10555312
-
项目类别:
-
资助金额:$136.97万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats
-
批准号:10088385
-
项目类别:
-
资助金额:$439.05万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Core B: Industrialization Core
-
批准号:10088388
-
项目类别:
-
资助金额:$10.18万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Project II: Biologics Engineering and Antibody Mechanism of Action
-
批准号:10088393
-
项目类别:
-
资助金额:$166.21万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Core A: Administrative Core
-
批准号:10555305
-
项目类别:
-
资助金额:$23.89万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Core A: Administrative Core
-
批准号:10088386
-
项目类别:
-
资助金额:$16.17万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats
-
批准号:10555304
-
项目类别:
-
资助金额:$430.31万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Core B: Industrialization Core
-
批准号:10555307
-
项目类别:
-
资助金额:$115.18万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
In Vivo Efficacy Testing Core
-
批准号:10088390
-
项目类别:
-
资助金额:$71.95万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
In Vivo Efficacy Testing Core
-
批准号:10555309
-
项目类别:
-
资助金额:$136.79万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Project I: Discovery and Evaluation of Antibodies and Cocktails
-
批准号:10555311
-
项目类别:
-
资助金额:$101.71万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Project I: Discovery and Evaluation of Antibodies and Cocktails
-
批准号:10088391
-
项目类别:
-
资助金额:$174.54万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Dissecting the receptor-mediated infection mechanisms of hantaviruses
-
批准号:10203768
-
项目类别:
-
资助金额:$41.26万
-
财政年份:2017
-
负责人:Kartik Chandran
-
依托单位:
A "Trojan Horse" bispecific antibody strategy for broad filovirus therapeutics
-
批准号:10192496
-
项目类别:
-
资助金额:$108.42万
-
财政年份:2017
-
负责人:Kartik Chandran
-
依托单位:
海外基金